87
Risk estimation tools are everywhere, yet ASCVD deaths remain high. What’s missing? Our data tells us the story.
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the U.S., with heart disease accounting for 12% of total healthcare expenditures. While risk estimation tools have been widely recommended, ASCVD mortality rates remain unchanged. This report leverages Veradigm Network EHR data to analyze 10-year ASCVD risk across demographics and geography, offering actionable insights for life science professionals.
What’s Inside:
- Insights and trends from the Veradigm Network in ASCVD risk estimation and prevention strategies
- Analysis of 10-year ASCVD risk scores across U.S. populations
- Geographic and demographic variations in cardiovascular risk
- The role of real-world EHR data in understanding ASCVD patterns
- Future innovations, including AI and digital health interventions
Gain valuable insights into ASCVD risk and prevention. Download the report today.
Offered Free by: Veradigm
See All Resources from: Veradigm